GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Sarepta Therapeutics Inc (SRPT) [hlAlert]

Rating:
Sell SRPT
down 48.19 %

Sarepta Therapeutics Inc (SRPT) downgraded to Sell by Citigroup

Posted on: Monday,  Jan 6, 2014  8:25 AM ET by Citigroup

Citigroup rated Sell Sarepta Therapeutics Inc (NASDAQ: SRPT) on 01/06/2014, when the stock price was $18.77. Since
then, Sarepta Therapeutics Inc has gained 93.02% as of 01/19/2016's recent price of $36.23.
If you would have followed this Citigroup's recommendation on SRPT, you would have lost 48.19% of your investment in 743 days.

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI's NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/6/2014 8:25 AM Sell
None
18.77
as of 10/17/2014
1 Week down  -18.80 %
1 Month up  2.78 %
3 Months down  -7.88 %
1 YTD down  -18.80 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/27/2013 8:25 AM Hold
None
34.25

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy